Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing

Clinical Trial Description

To further evaluate accelerated fading resulting from additional treatment sessions of multi-pass Q-Switched laser with the Soliton Planar Acoustic Wave Device System (AWD) as an accessory to Q-Switched laser in tattoo reduction treatment. ;

Study Design

Related Conditions & MeSH terms

Tattooing

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05371795` - Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device	N/A
Terminated	`NCT01516034` - The Efficacy of the Cupola Ultrasonic Tattoo Removal Device	N/A
Completed	`NCT06132295` - Adoption of Multiple Strategies to Reduce the Rate of Marker Detachment During Radiotherapy in Patients With Cancer	N/A

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT05371795 - Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device

N/A

Terminated

NCT01516034 - The Efficacy of the Cupola Ultrasonic Tattoo Removal Device

N/A

Completed

NCT06132295 - Adoption of Multiple Strategies to Reduce the Rate of Marker Detachment During Radiotherapy in Patients With Cancer

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03125824
Study type	Interventional
Source	Soliton
Contact
Status	Completed
Phase	N/A
Start date	February 13, 2017
Completion date	September 25, 2018

Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial Protocol

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms